EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
-0.77%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$3.11B
AUM Growth
+$3.11B
(-5.5%)
Cap. Flow
-$28.2M
Cap. Flow
% of AUM
-0.91%
Top 10 Holdings %
Top 10 Hldgs %
73.57%
Holding
71
New
5
Increased
9
Reduced
9
Closed
13
Top Buys
| 1 |
Janux Therapeutics
JANX
|
$29.2M |
| 2 |
Zymeworks
ZYME
|
$22.8M |
| 3 |
Galapagos
GLPG
|
$19.9M |
| 4 |
Revolution Medicines
RVMD
|
$19.4M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$17.7M |
Top Sells
| 1 |
Zai Lab
ZLAB
|
$66.2M |
| 2 |
Ventyx Biosciences
VTYX
|
$13.1M |
| 3 |
TSVT
2seventy bio
TSVT
|
$10.7M |
| 4 |
Geron
GERN
|
$9.75M |
| 5 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
$9.72M |
Sector Composition
| 1 | Healthcare | 99.82% |
| 2 | Financials | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Prothena Corp
PRTA
$441M
| $561M | 18.08% | 11,584,280 | – | – |
|
2
Sarepta Therapeutics
SRPT
$1.78B
| $413M | 13.31% | 2,999,453 | – | – |
|
|
3
Apellis Pharmaceuticals
APLS
$3.48B
| $360M | 11.58% | 5,451,647 +268,216 | +5% | +$17.7M |
|
|
4
Galapagos
GLPG
$2.07B
| $164M | 5.28% | 4,244,645 +513,915 | +14% | +$19.9M |
|
5
AnaptysBio
ANAB
$569M
| $164M | 5.27% | 7,521,024 | – | – |
|
6
Xencor
XNCR
$580M
| $147M | 4.74% | 5,282,516 | – | – |
|
|
MORF
7
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $145M | 4.66% | 3,846,966 -104,600 | -3% | -$3.94M |
|
|
8
Revolution Medicines
RVMD
$7.1B
| $116M | 3.73% | 5,352,183 +893,452 | +20% | +$19.4M |
|
9
Acadia Pharmaceuticals
ACAD
$4.38B
| $113M | 3.63% | 5,991,479 | – | – |
|
10
Arvinas
ARVN
$568M
| $102M | 3.27% | 3,717,788 +594,488 | +19% | +$16.2M |
|
|
11
Zymeworks
ZYME
$1.12B
| $91.2M | 2.94% | 10,087,473 +2,518,900 | +33% | +$22.8M |
|
|
SWTX
12
DELISTED
SpringWorks Therapeutics
SWTX
| $89.1M | 2.87% | 3,460,208 | – | – |
|
13
Kura Oncology
KURA
$686M
| $81.2M | 2.61% | 6,638,371 | – | – |
|
14
Relay Therapeutics
RLAY
$619M
| $68.6M | 2.21% | 4,163,824 | – | – |
|
|
15
Janux Therapeutics
JANX
$1.37B
| $46.4M | 1.5% | 3,838,486 +2,417,167 | +170% | +$29.2M |
|
16
Voyager Therapeutics
VYGR
$186M
| $29.7M | 0.96% | 3,851,507 -902,400 | -19% | -$6.96M |
|
17
Dyne Therapeutics
DYN
$1.92B
| $26.8M | 0.86% | 2,322,384 | – | – |
|
|
NGM
18
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $26.3M | 0.85% | 6,435,518 | – | – |
|
19
Alector
ALEC
$238M
| $25.1M | 0.81% | 4,056,548 | – | – |
|
20
Kymera Therapeutics
KYMR
$2.95B
| $23.6M | 0.76% | 796,093 | – | – |
|
21
Edgewise Therapeutics
EWTX
$1.51B
| $23.3M | 0.75% | 3,493,194 | – | – |
|
22
Nuvation Bio
NUVB
$1.02B
| $23.1M | 0.74% | 13,896,543 | – | – |
|
23
Allogene Therapeutics
ALLO
$251M
| $22.2M | 0.71% | 4,488,200 | – | – |
|
|
CNTA
24
Centessa Pharmaceuticals
CNTA
$2.25B
| $21.6M | 0.7% | 5,618,779 +386,500 | +7% | +$1.49M |
|
25
Crinetics Pharmaceuticals
CRNX
$2.92B
| $21.4M | 0.69% | 1,330,263 | – | – |
|